A phase II study of cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas

被引：0
|
作者：
Agulnik, Mark
Okuno, Scott H.
Van Tine, Brian Andrew
Pollack, Seth
Weiss, Mia C.
Hirbe, Angela C.
Viveiros, Pedro
Schulte, Brian
Frankel, Paul Henry
Attia, Steven
Siontis, Brittany L.
Milhem, Mohammed M.
Monga, Varun
Charlson, John A.
Robinson, Steven Ian
Yoon, Janet
机构：
[1] City Hope Comprehens Canc Ctr, Durarte, CA USA
[2] Mayo Clin, Rochester, MN USA
[3] Washington Univ St Louis, St Louis, MO USA
[4] Northwestern Univ, Chicago, IL USA
[5] Washington Univ, Sch Med, St Louis, MO USA
[6] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[7] Mayo Clin, Jacksonville, FL USA
[8] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA
[9] Univ Iowa, Iowa City, IA USA
[10] Med Coll Wisconsin, Milwaukee, WI USA
[11] City Hope Natl Med Ctr, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11505
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of temozolomide and thalidomide in patients with unresectable or metastatic leiomyosarcoma.
    Boyar, M
    Keohan, ML
    Hesdorffer, M
    Taub, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 823S - 823S
  • [2] A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma
    Talbot, SM
    Keohan, ML
    Hesdorffer, M
    Orrico, R
    Bagiella, E
    Troxel, AB
    Taub, RN
    CANCER, 2003, 98 (09) : 1942 - 1946
  • [3] A phase I/II study of azacitidine in combination with temozolomide in patients with unresectable or metastatic soft tissue sarcoma or malignant mesothelioma.
    Bates, Gleneara Elizabeth
    Taub, Robert N.
    Matushansky, Igor
    Uldrick, Thomas S.
    Khandker, Maya
    Bressler, Yaakov
    Wang, Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas
    Trent, JC
    Beach, J
    Burgess, MA
    Papadopolous, N
    Chen, LL
    Benjamin, RS
    Patel, SR
    CANCER, 2003, 98 (12) : 2693 - 2699
  • [5] A phase II study tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas
    Nye, Lauren Elizabeth
    Polish, Ariel
    Abbinanti, Susan E.
    Vintilescu, Claudia Rosana
    Rademaker, Alfred
    Humphreys, Catherine
    Cehlc, Raslma
    McFarland, Thomas
    Milhem, Mohammed M.
    Skubitz, Keith M.
    Van Tine, Brian Andrew
    Okuno, Scott H.
    Aguinik, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas
    D'Adamo, DR
    Anderson, SE
    Albritton, K
    Yamada, J
    Riedel, E
    Scheu, K
    Schwartz, GK
    Chen, H
    Maki, RG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7135 - 7142
  • [7] A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas
    Agulnik, M.
    Costa, R. L. B.
    Milhem, M.
    Rademaker, A. W.
    Prunder, B. C.
    Daniels, D.
    Rhodes, B. T.
    Humphreys, C.
    Abbinanti, S.
    Nye, L.
    Cehic, R.
    Polish, A.
    Vintilescu, C.
    McFarland, T.
    Skubitz, K.
    Robinson, S.
    Okuno, S.
    Van Tine, B. A.
    ANNALS OF ONCOLOGY, 2017, 28 (01) : 121 - 127
  • [8] A phase II study of tivozanib in patients with metastatic and non-resectable soft tissue sarcomas
    Agulnik, Mark
    Milhem, Mohammed M.
    Rademaker, Alfred
    Humphreys, Catherine
    Abbinanti, Susan E.
    Nye, Lauren Elizabeth
    Cehic, Rasima
    Polish, Ariel
    Vintilescu, Claudia Roxana
    McFarland, Thomas
    Skubitz, Keith M.
    Robinson, Steven Ian
    Okuno, Scott H.
    Van Tine, Brian Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Phase II study of sunitinib malate (SM) in subjects with metastatic and/or surgically unresectable non-GIST soft tissue sarcomas
    Vigil, C. E.
    Chiappori, A. A.
    Williams, C. A.
    Shrager, H. H.
    Murray, B. L.
    Letson, D. G.
    Sullivan, D. M.
    Garrett, C. R.
    D'Amato, G. Z.
    Agresta, S. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas
    Maki, Robert G.
    Wathen, J. Kyle
    Patel, Shreyaskumar R.
    Priebat, Dennis A.
    Okuno, Scott H.
    Samuels, Brian
    Fanucchi, Michael
    Harmon, David C.
    Schuetze, Scott M.
    Reinke, Denise
    Thall, Peter F.
    Benjamin, Robert S.
    Baker, Laurence H.
    Hensley, Martee L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) : 2755 - 2763
12345